IMM.L
ImmuPharma Plc
Latest RNS
Powered by
Vox Markets
Immupharma PLC - Dual Listing on Euronext Growth Brussels
more
Immupharma PLC - Share Price Volatility
more
Immupharma PLC - IMMUPHARMA TO PRESENT AT BIOTECH SHOWCASET 2020
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - Licence Agreement for Lupuzor with Avion in US
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Interim Results Announcement
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - TR-1: notification of major holdings
more
Immupharma PLC - Update on Lupuzor
more
Immupharma PLC - 2019 Annual General Meeting
more
Immupharma PLC - Subscription to raise £2.66 million
more
Immupharma PLC - Notice of AGM and posting of Report & Accounts
more
Immupharma PLC - FINAL RESULTS
more
Immupharma PLC - Corporate Update - Replacement
more
Immupharma PLC - Corporate Update - Replacement
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Update on Nucant Cancer Programme
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Technology review published-Nature Communications
more
Immupharma PLC - Clinical Development Collaboration with Incanthera
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Appointment of Nominated Adviser
more
Immupharma PLC - Update on Corporate Activities
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Nominated Adviser Status
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Appointment of Joint Brokers
more
Immupharma PLC - Corporate Update
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Results of CIDP Pre-Clinical Data
more
Immupharma PLC - Notice of AGM & Posting of Annual Report
more
Immupharma PLC - Final Results
more
Immupharma PLC - Update on Pivotal Phase III Trial of Lupuzor
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Topline results of Lupuzor Pivotal Phase III Trial
more
Immupharma PLC - Appointment of Joint Broker
more
Immupharma PLC - Lupuzor Pivotal Phase III Study Update
more
Immupharma PLC - AIM Notice (17)
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Last patient completes dosing in LupuzorT Trial
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Completion of Lanstead Sharing Agreement
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Preparation of Lupuzor'sT Regulatory Submissions
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Notification of Interim Results
more
Immupharma PLC - AIM Rule 17 Notice
more
Immupharma PLC - Grant of Options
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
more
Immupharma PLC - Annual Report & Notice of AGM
more
Immupharma PLC - Final Results
more
Immupharma PLC - Notification of Full Year Results
more
Immupharma PLC - Update on Lupuzor Phase III Study
more
Immupharma PLC - New Employee Share Option Plan & Grant of Options
more
Immupharma PLC - New Employee Share Option Plan & Grant of Options
more
Immupharma PLC - ImmuPharma to present at Master Investor Show
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - £4.1 Million Fund Raise via Accelerated Bookbuild
more
Immupharma PLC - Accelerated Bookbuild for the Issue of Equity
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Update on Lupuzor Phase III Study
more
Immupharma PLC - Change of Adviser
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Update on Lupuzor Pivotal Phase III Study
more
Immupharma PLC - Update on Cancer Compound IPP-204106 'Nucant'
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Close of Accelerated Bookbuild
more
Immupharma PLC - Proposed Accelerated Bookbuild for Vendor Placing
more
Immupharma PLC - Half-year Report
more
Immupharma PLC - UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY
more
Immupharma PLC - UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Second Price Monitoring Extn
more
Immupharma PLC - Price Monitoring Extension
more
Immupharma PLC - Appointment of Joint Broker
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Symposium with Lupuzors Inventor Prof. S Muller
more
Immupharma PLC - European Patients Commence Dosing in Lupuzor
more
Immupharma PLC - Director/PDMR Shareholding
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Annual Financial Report & Notice of AGM
more
Immupharma PLC - Final Results
more
Immupharma PLC - Notice of Results
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - First European Site Opens - Patient Recruitment
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - EIS and VCT Qualifying Status and Issue of Equity
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Issue of Equity
more
Immupharma PLC - Result of GM
more
Immupharma PLC - US PATIENTS COMMENCE DOSING IN PHASE III STUDY
more
Immupharma PLC - Placing and Subscription Raises £8.3 million
more
Immupharma PLC - Proposed Placing and Subscription
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - ImmuPharma & Simbec-Orion - Investigators Meeting
more
Immupharma PLC - Update on the progress of Lupuzor
more
Immupharma PLC - Holding(s) in Company
more
Immupharma PLC - Lupuzor Phase III Pivotal Trial Update
more
Immupharma PLC - Lupuzor Phase III Pivotal Trial Update
more
Immupharma PLC - Directorate Change
more
Immupharma PLC - Directorate Change
more
Immupharma PLC - Interim Results
more
Immupharma PLC - Richard Warr
more
Immupharma PLC - TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR
more
Immupharma PLC - Lupuzor's Founder Dr Slyviane Muller Awarded Medal
more
Immupharma PLC - Result of AGM
more
Immupharma PLC - Annual Report & Accounts
more
Immupharma PLC - Interim Board Change
more
Immupharma PLC - Directorate Change
more
Immupharma PLC - Preliminary Results
more
Immupharma PLC - Enterprise Investment Scheme Status
more
Immupharma PLC - Collaboration Agreement with Simbec-Orion
more